| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | CASTLIGHT HEALTH INC COM CL B | 10,229 | 51,000 | 0.00% | ||
| 2 | ADVERUM BIOTECHNOLOGIES INC | 22,236 | 64,000 | 0.01% | ||
| 3 | AURINIA PHARMACEUTICALS INC | 36,743 | 77,000 | 0.01% | ||
| 4 | UNITEDHEALTH GROUP INC | 1,820 | 291,000 | 0.03% | ||
| 5 | ISHARES TR | 4,500 | 1,194,000 | 0.10% | ||
| 6 | DIPLOMAT PHARMACY INC COM | 153,317 | 1,932,000 | 0.17% | ||
| 7 | ACLARIS THERAPEUTICS INC COM | 94,200 | 2,557,000 | 0.22% | ||
| 8 | RA PHARMACEUTICALS INC COM | 180,310 | 2,739,000 | 0.24% | ||
| 9 | FATE THERAPEUTICS INC | 1,419,058 | 3,562,000 | 0.31% | ||
| 10 | DYNAVAX TECHNOLOGIES CORP | 1,049,791 | 4,147,000 | 0.36% | ||
| 11 | GLOBAL BLOOD THERAPEUTICS INCORPORATED | 316,400 | 4,572,000 | 0.39% | ||
| 12 | SPECTRANETICS CORP | 187,627 | 4,597,000 | 0.40% | ||
| 13 | VCA INCORPORATED | 70,040 | 4,808,000 | 0.41% | ||
| 14 | iRhythm Technologies, Inc. | 228,800 | 6,864,000 | 0.59% | ||
| 15 | ENDOLOGIX INC | 1,206,894 | 6,903,000 | 0.60% | ||
| 16 | MODEL N INCORPORATED | 809,914 | 7,168,000 | 0.62% | ||
| 17 | CYTOMX THERAPEUTICS INC COM | 696,992 | 7,660,000 | 0.66% | ||
| 18 | ProQR Therapeutics NV | 1,578,174 | 7,733,000 | 0.67% | ||
| 19 | INVITAE CORP | 1,065,002 | 8,456,000 | 0.73% | ||
| 20 | BOSTON SCIENTIFIC CORP | 459,505 | 9,939,000 | 0.86% | ||
| 21 | EHEALTH INC COM | 997,621 | 10,625,000 | 0.92% | ||
| 22 | ANTHEM INC | 77,223 | 11,102,000 | 0.96% | ||
| 23 | SYROS PHARMACEUTICALS INC | 948,440 | 11,533,000 | 0.99% | ||
| 24 | ARRAY BIOPHARMA INC 3 06/01/2020 | 9,000,000 | 12,593,000 | 1.09% | PRN | |
| 25 | PATHEON N V | 440,720 | 12,653,000 | 1.09% | ||
| 26 | Audentes Therapeutics, Inc. | 832,736 | 15,214,000 | 1.31% | ||
| 27 | CHIMERIX INC | 3,345,959 | 15,391,000 | 1.33% | ||
| 28 | CHARLES RIV LABS INTL INC | 247,107 | 18,827,000 | 1.62% | ||
| 29 | NEVRO CORP COM | 260,380 | 18,919,000 | 1.63% | ||
| 30 | ALDER BIOPHARMACEUTICALS INC | 920,550 | 19,147,000 | 1.65% | ||
| 31 | NANOSTRING TECHNOLOGIES INC | 937,957 | 20,916,000 | 1.80% | ||
| 32 | EXPRESS SCRIPTS HLDG CO | 338,800 | 23,306,000 | 2.01% | ||
| 33 | WAVE LIFE SCIENCES LTD | 951,712 | 24,887,000 | 2.15% | ||
| 34 | Oxford Immunotec Global PLC | 1,701,049 | 25,431,000 | 2.19% | ||
| 35 | XENCOR INC COM | 996,100 | 26,217,000 | 2.26% | ||
| 36 | CENTENE CORP DEL | 516,598 | 29,193,000 | 2.52% | ||
| 37 | AGIOS PHARMACEUTICALS INC | 738,451 | 30,816,000 | 2.66% | ||
| 38 | PROTHENA CORP PLC | 653,725 | 32,157,000 | 2.77% | ||
| 39 | NEURODERM LTD | 1,560,819 | 34,650,000 | 2.99% | ||
| 40 | Atara Biotherapeutics Inc | 2,670,942 | 37,927,000 | 3.27% | ||
| 41 | PUMA BIOTECHNOLOGY | 1,290,140 | 39,607,000 | 3.41% | ||
| 42 | GW PHARMACEUTICALS PLC | 366,068 | 40,908,000 | 3.53% | ||
| 43 | MOLINA HEALTHCARE INC | 805,546 | 43,709,000 | 3.77% | ||
| 44 | INCYTE CORP | 451,987 | 45,321,000 | 3.91% | ||
| 45 | ARIAD PHARMACEUTICALS ORD (NMS) | 3,838,376 | 47,749,000 | 4.12% | ||
| 46 | AMICUS THERAPEUTICS INC COM | 12,331,130 | 61,286,000 | 5.28% | ||
| 47 | PENUMBRA INC COM | 1,040,208 | 66,365,000 | 5.72% | ||
| 48 | CLOVIS ONCOLOGY INC | 1,620,355 | 71,976,000 | 6.20% | ||
| 49 | SEATTLE GENETICS INC | 1,520,904 | 80,258,000 | 6.92% | ||
| 50 | ARRAY BIOPHARMA INC | 16,618,776 | 146,079,000 | 12.59% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001425738-17-000010, filed 2017.02.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
